Evidence map›Paper›PMID 32528090›Full record

ArticleNature2020

Leveraging excited-state coherence for synthetic control of ultrafast dynamics.

Bryan C Paulus, Sara L Adelman, Lindsey L Jamula, James K McCusker

Erratum issued Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT07356466 (Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma), which is not on this map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07356466 early_phase1enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Center Randomized Controlled Trial

TypeinterventionalSponsorFujian Medical UniversityRan2025 to 2030Enrolled100ConditionsGastric (Stomach) CancerArmsPucotenlimab Combined with Lenvatinib, Oxaliplatin plus S-1 regimen
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 123 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Real-Time Tracking of Photoinduced Metal-Metal Bond Formation in a dJournal of the American Chemical Society · 2025
    Article
  12. Article
  13. A numerically exact description of ultrafast vibrational decoherence in vibration-coupled electron transfer.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  14. Article
  15. Article
  16. Multifaceted Deactivation Dynamics of Fe(II)The journal of physical chemistry. A · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Bryan C Paulus *Department of Chemistry, Michigan State University, East Lansing, MI, USA.
Sara L Adelman *Department of Chemistry, Michigan State University, East Lansing, MI, USA.
Lindsey L JamulaDepartment of Chemistry, Michigan State University, East Lansing, MI, USA.
James K McCuskerDepartment of Chemistry, Michigan State University, East Lansing, MI, USA. jkm@chemistry.msu.edu.
Michigan State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Design-specific control over excited-state dynamics is necessary for any application seeking to convert light into chemical potential. Such control is especially desirable in iron(II)-based chromophores, which are an Earth-abundant option for a wide range of photo-induced electron-transfer applications including solar energy conversion

Identifiers

PMID32528090
OpenAlexW3034187114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.